NRC Health (NRC) - Q2 2025 10-Q Summary
Business Context and Reporting Period
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare organizations focusing on patient and employee experience. This report covers the quarterly period ended June 30, 2025. Effective June 1, 2025, Trent Green assumed the role of Chief Executive Officer, with Michael Hays transitioning to Chairman.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenue | $34.0 million | $35.0 million | $67.6 million | $70.3 million |
| Operating Income | $1.6 million | $8.9 million | $10.2 million | $17.6 million |
| Net Income (Loss) | $(0.1) million | $6.2 million | $5.7 million | $12.5 million |
| Operating Margin | 5% | 25% | 15% | 25% |
| Effective Tax Rate | 118% | 26% | 32% | 24% |
| Cash from Operations (YTD) | $5.5 million (vs. $18.8 million YTD 2024) | |||
| Total Debt (Gross) | $82.4 million (Delayed Draw Term Loan) | |||
| Cash & Equivalents | $5.3 million |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 3% in Q2 and 4% YTD compared to 2024. This was driven by a $1.3 million decrease in recurring revenue from existing clients and a $134,000 drop in non-recurring revenue, partially offset by $419,000 in new client revenue.
- SG&A Spike: Selling, general, and administrative expenses increased 58% in Q2 and 25% YTD. This was primarily due to $6.6 million in cash bonuses and increased share-based compensation related to new executive compensation arrangements for the new CEO and existing leadership.
- Profitability Impact: Operating income dropped 82% in Q2 and 42% YTD. The effective tax rate surged to 118% in Q2 due to deductible limitations on executive cash bonuses.
- Debt Restructuring: In February 2025, the company entered a new credit agreement, extinguishing prior debt (recognizing a $67,000 loss) and establishing a $110 million Delayed Draw Term Loan and a $30 million Revolving Loan. Borrowings increased significantly to fund share repurchases and capital expenditures.
Guidance, Outlook, and Risks
- Outlook: Management expects operating income and margins to improve in the near term due to revenue and cost initiatives, excluding the one-time impact of executive compensation charges. Total Recurring Contract Value (TRCV) increased sequentially in Q1 and Q2 2025 but remains lower than Q2 2024.
- Capital Allocation: The company prioritizes innovation and growth investments, followed by dividends and share repurchases. A new $20 million stock repurchase program was authorized in April 2025; $5.8 million was utilized in Q2.
- Liquidity: Despite a working capital deficit of $10.6 million, the company maintains $5.3 million in cash and $57.6 million in available borrowing capacity ($30M Revolver + $27.6M Term Loan). Management believes liquidity is sufficient for foreseeable needs.
- Risks: Key risks include client non-renewal, competitive price pressure, and the impact of the new executive compensation structure on future margins. The company is also evaluating the impact of the "One Big Beautiful Bill Act" signed July 4, 2025, though no material impact is currently expected.
Investor Verification Checklist
- Executive Compensation Impact: Verify the sustainability of SG&A expenses given the $6.6 million in cash bonuses and future non-cash equity charges ($770k quarterly through 2028).
- TRCV Trends: Monitor Total Recurring Contract Value closely as a leading indicator, noting it is still down year-over-year despite sequential improvement.
- Debt Service: Review the impact of the increased interest expense ($1.0M in Q2 vs $0.6M in Q2 2024) on future cash flows given the higher principal balance on the Delayed Draw Term Loan.
- Tax Rate Volatility: Assess the likelihood of the effective tax rate normalizing in future quarters once the specific executive bonus limitations are resolved.
- Capital Expenditures: Confirm the completion and ROI of the $6.0 million in YTD capital expenditures, primarily for building renovations and software development.